BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, May 12, 2026
Home » Authors » John Brosky

Articles by John Brosky

Marie Curie brings first mobile X-ray to the battlefield front line

Dec. 3, 2014
By John Brosky

iHealth realigns wearable devices to thrive in post-Apple market

Dec. 1, 2014
By John Brosky

Medica 2014: HistoIndex brings stain-free, 3-D digital pathology to the lab

Nov. 19, 2014
By John Brosky

Medica 2014: Stitch in time opens panoramic view for surgeons in keyhole surgery

Nov. 18, 2014
By John Brosky

Medica 2014: Molecular diagnostics continue moving from lab to the stomach

Nov. 17, 2014
By John Brosky
DÜSSELDORF, Germany — Moving a microscope from the pathologist's bench into an endoscope broke new ground and carved out a niche in the assessment of gastroenterological and pulmonary diseases for Mauna Kea Technologies (MKT; Paris).
Read More

Medica 2014: German med-techs claw 4.5% gain against headwinds in world markets

Nov. 14, 2014
By John Brosky
DÜSSELDORF, Germany — Considered the fourth pillar of the domestic economy, German medical device companies found growth again this year squeaking out a 4.5% increase in exports, according to Markus Braun, Chairman German Healthcare Export Group (GHE; Bonn, Germany).
Read More

Medica 2014: Cloud-sourcing personal data could potentially aid medical assessments

Nov. 13, 2014
By John Brosky
DÜSSELDORF, Germany — Health-related data is not necessarily healthcare data. Doctors turn their noses up at jazzy displays of blood pressure or glucose readings.
Read More

The MDD Interview: Svelte Medical aims to dominate transradial stenting stenting market

Nov. 5, 2014
By John Brosky

Untied European Gastroenterology Meeting: New products, big players pull pill cams out of niche market

Oct. 24, 2014
By John Brosky
VIENNA — Launched with great expectations almost 15 years ago, the pill camera has been pushed down to where it holds a stable, but narrow place in the gastroenterologist's diagnostic tool kit.
Read More

United European Gastroenterology Meeting: Robotic colonoscopy said to eliminate pain, reduces costs

Oct. 23, 2014
By John Brosky
VIENNA — Discomfort is the leading reason people give for not undergoing a colonoscopy, and the leading cause of non-compliance with this gold standard for colorectal cancer screening.
Read More
Previous 1 2 … 21 22 23 24 25 26 27 28 29 … 101 102 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 11, 2026.
  • Rendering of a key measles protein targeted by neutralizing human antibodies

    First measles treatment advances as vaccination rates drop

    BioWorld
    Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
  • Close up of bow of cruise ship

    Hantavirus is ‘sentinel’ more than acute pandemic threat

    BioWorld
    News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
  • Infensa Bioscience identifies new ASIC blockers

    BioWorld Science
    Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
  • Neurology illustration

    Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst

    BioWorld
    Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing